“…The rno‐miR‐184 has dual functions in cancers. It is an onco‐miRNA in osteosarcoma (Du, Li, Wang, Huang, & Xu, ), squamous cell carcinoma of tongue (Wong et al, ), but acts as a tumour suppressor in colorectal cancer (Wu, Liu, Wu, Wu, & Yao, ), breast cancer (Fu et al, ), even acts as both onco‐miRNA (Wu et al, ) and suppressor miRNA in glioma (Cheng et al, ). Although rno‐miR‐184 is an onco‐miRNA in prostate cancer (Lin, Chiang, Chang, & Ying, ; Walter, Valera, Pinto, & Merino, ), there is no evidence about relationship between rno‐miR‐184 and BPH.…”